Allison Dorval
Director · PUMA BIOTECHNOLOGY, INC.
- 2024
- Jun 16, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Allison Dorval files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Alessandra Cesano - $567K in PBYI purchases and sales in the last 12 months
- Alan H. Auerbach - $364K in PBYI purchases and sales in the last 12 months
- Adrian Senderowicz - $194K in PBYI purchases and sales in the last 12 months
- Jay M. Moyes - $159K in PBYI purchases and sales in the last 12 months
- Troy Edward Wilson - $123K in PBYI purchases and sales in the last 12 months
- Michael Patrick Miller - $97K in PBYI purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Allison Dorval?
Allison Dorval is a corporate insider, tracked as Director of PUMA BIOTECHNOLOGY, INC. (PBYI). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Allison Dorval last file a Form 4?
The most recent primary Form 4 on record is dated 16 June 2026, one of 3 filings going back to 2024.
Has Allison Dorval been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($87K) across all tracked filings.
